How Marijuana Legalization Affected OrganiGram and Aphria's Latest Results
These two marijuana stocks reported very different results last quarter. Plus, how Abbott's challenging Dexcom in diabetes, and what's next for Bristol-Myers following its Celgene acquisition.
No comments:
Post a Comment